FDA Inspection 1122375 — Claude T. Ashley, Jr., MD/PhD

Claude T. Ashley, Jr., MD/PhD — FEI 3008642680

The FDA completed an inspection of Claude T. Ashley, Jr., MD/PhD on March 18, 2020 in Dothan, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 18, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dothan, AL (United States)

Additional Details

Clinical Investigator (CI)